Syntropic is developing HAVEN, a non-invasive brain stimulation device that restores neuroplasticity to treat depression. By delivering precise pulsed light stimulation, HAVENTM activates microglia, the brain’s immune cells, to remodel extracellular structures that block neuroplasticity. Syntropic’s technology is based on pioneering discovery by our scientific co-founders Prof. Sandra Siegert and Dr. Alessandro Venturino at ISTA, Institute of Science and Technology Austria.
| Website | https://www.syntropicmedical.com |
| Employees | 11 (7 on RocketReach) |
| Founded | 2023 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Brain Plasticity, Brain Health Technology, Brain Health, Brain Stimulation, Cognitive Improvement, Cognitive Enhancement, Mental Health Treatment, Neurological Disorders, Neurological Treatment, Medical Device Technology, Cognitive Function, New Medical Technology, Medical Technology |
| Competitors | IBM, Siemens Healthineers, GE HealthCare, Philips, Lunit, Qure.ai, Zebra Medical Vision Ltd, CureMetrix, Aidoc, Google Health +37 more (view full list) |
Looking for a particular Syntropic employee's phone or email?
Syntropic Questions
Mark Caffrey is the Founder and CEO of Syntropic.
7 people are employed at Syntropic.
Syntropic is based in Vienna, Vienna.
Top Syntropic Employees
-
Alessandro Venturino
Managing Director at Syntropic
Klosterneuburg, AT2 -
Maria Ferretti
Head of Clinical at Syntropic
Vienna, Austria3 -
Josh Rombot
Head of Operations at Syntropic
Vienna, AT51 -
Amin Alam
Head of Engineering at Syntropic
Vienna, AT1 -
Frieda L.
Biomedical Researcher at Syntropic
Klosterneuburg, AT
Related Companies
